Angiogenesis and vascular targeting in Ewing sarcoma: a review of preclinical and clinical data.

Abstract

Ewing sarcoma is the second most common type of bone cancer in children and young adults. In recent years, the mechanisms by which these tumors develop and maintain their vascular supply have been elucidated. Additional work has demonstrated that inhibition of angiogenic pathways or disruption of established vasculature can attenuate the growth of Ewing sarcoma mouse xenografts. Early clinical data suggest that these results also may extend to patients with Ewing sarcoma who are treated with antiangiogenic or antivascular therapies. For the current review, the authors summarized the available data supporting this approach.

DOI: 10.1002/cncr.24844
010203020102011201220132014201520162017
Citations per Year

91 Citations

Semantic Scholar estimates that this publication has 91 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{DuBois2010AngiogenesisAV, title={Angiogenesis and vascular targeting in Ewing sarcoma: a review of preclinical and clinical data.}, author={Steven G DuBois and Neyssa M Marina and Julia L Glade-Bender}, journal={Cancer}, year={2010}, volume={116 3}, pages={749-57} }